Pharmacokinetic rationale of intraperitoneal therapy Intraperitoneal (IP) therapy represents a logical alternative means to deliver high drug concentrations to tumors located in the peritoneal ...

Understanding how drug delivery systems distribute in vivo remains a major challenge in developing nanomedicines. Especially ...

The assembled capsule was further tested in vivo to validate the actuation sequence and showed a 70% (n = 17) success rate in an animal model. Additionally, a drug delivery study indicated systemic ...